A study, published Jan. 3 in the journal Nature Communications, identifies a key pathway in gastric SCJ cancers that provides a promising target for future study and therapy. The researchers found that the progeny ...
Read More
Jan Lammerding is the senior author on new Cornell-led research paper which reports a strong connection between DNA damage triggered by mutations in proteins that surround the cell nucleus, known as lamins, and muscular ...
Read More
Researchers from the University of Hyderabad in India and the College of Veterinary Medicine have identified a compound that could be part of a strategy to improve the effectiveness of the dengue vaccine. Read ...
Read More
Dr. Carl Nathan, chairman of the Department of Microbiology and Immunology at Weill Cornell Medicine, has been awarded the Sanofi – Institut Pasteur Senior International Scientist Award for Biomedical Research in Microbiology and Infection. ...
Read More
Researchers are using glowing nanoparticles called C dots to detect multiple cancer markers during surgery in a way that is both precise and safe. Read the full story here.
An Immunoprofiling Workshop – sponsored by the Cornell Center for Immunology, Dec. 13 in Stocking Hall – will feature technology experts who will provide case studies and best practices on various core technologies. Read ...
Read More
A $4.2 million project at Cornell focused on 100 Alaskan sled dogs, former athletes past their glory days, is part of a quest for one of the holy grails of medicine: how to slow ...
Read More
A protein that breast, lung and other cancers use to promote their spread – or metastasis – to the brain, has been identified by a team led by Weill Cornell Medicine and NewYork-Presbyterian investigators. ...
Read More
A high-salt diet may impair cognitive function by causing a deficiency of nitric oxide, which is vital for maintaining vascular health in the brain, according to a new study from Weill Cornell Medicine. Read ...
Read More
A universal influenza vaccine developed with the potential to be longer lasting and more effective than commercially available vaccines is destined for human clinical trials, thanks to a $17.9 million grant from the National ...
Read More
